Studying the efficacy of Lidocaine in reducing the incidence of laryngospsam in children undergoing surgical removal of adenoids and tonsills

Efficacy of Intravenous lidocaine in preventing Perioperative respiratory adverse events in children after adenoidectomy and tonsillectomy procedures.

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12626000346370

Enrollment

150

Registered

2026-03-19

Start date

2026-04-01

Completion date

2026-06-02

Last updated

2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Children undergoing adenotonsillectomy has a high incidence of developing respiratory adverse effects as spasm in the upper airway and drop in their oxygen saturation . lidocaine may be effective in reducing the incidence of such problems in these children . We are going to study its efficacy in reducing the incidence of such complications.

Interventions

- Patients in one of the 2 groups will receive IV lidocaine 5 minutes before extubation - 1.5 mg/kg intravenous - the anesthesiologist will be the one to administer - medical documents will be used to assess adherence to intervention

Study design

Allocation

Randomised controlled trial

Primary purpose

Treatment

Eligibility

Sex/Gender

All

Age

1 Years to 10 Years

Healthy volunteers

Inclusion criteria

American society of anesthesiologist 1 & 2 Children undergoing adenotonsillectomy

Exclusion criteria

Children with chronic respiratory disease Children with cardiac disease Allergy to lidocaine

Outcome results